Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
9
×
ipo
9
×
life sciences
national blog main
startups
9
×
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
boston top stories
cancer
deals
new york top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
eli lilly
clinical trials
novartis
takeda pharmaceutical
allergan
alzheimer's disease
biogen
cancer immunotherapy
What
bio
roundup
ipo
new
drugs
medicines
pharmaceutical
biotech
black
companies
company
covid
deal
debut
developing
diamond’s
life
plans
public
raise
science
therapeutics
typically
acquisitions
activity
advance
aiming
alzheimer’s
ambys
announced
appetite
approvals
bails
big
biogen
biology
brand
bread
bridgebio
butter
Language
unset
Current search:
ipo
×
startups
×
" boston blog main "
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?